FDA Panel Endorses Use of Moderna's COVID Vaccine
On Thursday, the FDA's advisory panel endorsed Moderna's Covid-19 vaccine.
Now the vote will go before FDA officials who will determine whether to grant emergency use authorization for the vaccine.
The Moderna vaccine proved to be over 90% effective in late stage trials and is widely expected to receive emergency use approval over the next few days. If approved, Moderna's vaccine would be the second vaccine to receive emergency use authorization after Pfizer and BioNTech received it for their vaccine a few days ago.
If approved, Moderna vaccines could start rolling out to citizens as early as next week.
Photo Source: fda.gov